Your browser is no longer supported. Please, upgrade your browser.
Settings
CORI Corium International, Inc. daily Stock Chart
CORI [NASD]
Corium International, Inc.
Index- P/E- EPS (ttm)-1.57 Insider Own0.90% Shs Outstand36.37M Perf Week-0.16%
Market Cap456.81M Forward P/E- EPS next Y-1.33 Insider Trans-91.98% Shs Float35.87M Perf Month33.62%
Income-56.60M PEG- EPS next Q-0.31 Inst Own- Short Float10.03% Perf Quarter64.40%
Sales36.50M P/S12.52 EPS this Y0.20% Inst Trans0.27% Short Ratio4.43 Perf Half Y25.10%
Book/sh0.69 P/B18.20 EPS next Y12.50% ROA-57.50% Target Price13.00 Perf Year22.90%
Cash/sh2.27 P/C5.54 EPS next 5Y- ROE-276.80% 52W Range7.17 - 13.93 Perf YTD30.70%
Dividend- P/FCF- EPS past 5Y-38.20% ROI-58.10% 52W High-9.83% Beta1.07
Dividend %- Quick Ratio7.50 Sales past 5Y-5.80% Gross Margin26.50% 52W Low75.17% ATR0.48
Employees213 Current Ratio7.60 Sales Q/Q-4.90% Oper. Margin- RSI (14)76.90 Volatility0.37% 3.74%
OptionableYes Debt/Eq2.83 EPS Q/Q19.60% Profit Margin- Rel Volume0.84 Prev Close12.53
ShortableYes LT Debt/Eq2.83 EarningsNov 15 AMC Payout- Avg Volume812.06K Price12.56
Recom2.20 SMA2024.32% SMA5030.55% SMA20025.02% Volume671,467 Change0.24%
Dec-27-17Reiterated H.C. Wainwright Buy $15 → $14
Dec-26-17Reiterated Needham Buy $16 → $14
Nov-20-17Reiterated Needham Buy $13 → $16
Sep-26-17Initiated H.C. Wainwright Buy $15
Aug-07-17Reiterated Jefferies Buy $8 → $10
Apr-18-17Reiterated FBR & Co. Outperform $12 → $13
Feb-14-17Reiterated Needham Buy $12 → $10
May-03-16Upgrade WBB Securities Hold → Speculative Buy $11
Feb-09-16Reiterated Needham Buy $16 → $15
Nov-16-15Reiterated Needham Buy $18 → $16
Aug-31-15Downgrade WBB Securities Buy → Hold $5.75 → $11
Jun-18-15Reiterated Needham Buy $12 → $18
Jun-09-15Initiated Guggenheim Buy
Jun-05-15Reiterated FBR Capital Outperform $12 → $16
May-08-15Reiterated Leerink Partners Outperform $10 → $13
May-08-15Reiterated FBR Capital Outperform $10 → $12
Apr-02-15Resumed FBR Capital Outperform $10
Apr-28-14Initiated Needham Buy $12
Apr-28-14Initiated FBR Capital Outperform $11
Oct-19-18 05:40PM  WeissLaw LLP Investigates Corium International, Inc. Acquisition ACCESSWIRE
Oct-17-18 08:40AM  Factors of Influence in 2018, Key Indicators and Opportunity within Gogo, Jagged Peak Energy, Everbridge, Roku, Corium International, and Ionis Pharmaceuticals New Research Emphasizes Economic Growth GlobeNewswire
Oct-16-18 06:50PM  SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation into the Fairness of the Sale Price of Corium International, Inc. - CORI ACCESSWIRE
05:45PM  MERGER ANNOUNCEMENT: Monteverde & Associates PC Announces An Investigation Of Corium International, Inc. - CORI ACCESSWIRE
05:29PM  MERGER ALERT RDC, CORI and ESL: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies GlobeNewswire
Oct-15-18 10:59AM  RM LAW Announces Investigation of Corium International, Inc. PR Newswire
10:39AM  Corium's (CORI) Shares Surge on Merger Agreement With Gurnet Zacks
08:00AM  Todays Research Reports on Stocks to Watch: Corium and Verastem ACCESSWIRE
Oct-12-18 08:00PM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Corium International, Inc. - CORI PR Newswire +52.83%
04:42PM  Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Corium International, Inc. (CORI) on Behalf of Stockholders and Encourages CORI Investors to the Firm GlobeNewswire
12:43PM  ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Corium International, Inc. PR Newswire
11:32AM  Why Corium International Inc. Stock Is Skyrocketing Today Motley Fool
10:30AM  CORIUM INTERNATIONAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout Business Wire
09:57AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Corium International, Inc. to Gurnet Point Capital is Fair to Shareholders GlobeNewswire
08:49AM  [$$] Corium Agrees to Take-Private; Greenbriar's Latest Logistics Play The Wall Street Journal
08:16AM  Corium's stock rockets to pace premarket gainers after Gurnet buyout deal MarketWatch
07:25AM  Corium (CORI) Alert: Johnson Fistel Investigates Proposed Sale of Corium International, Inc. to Gurnet Point Capital; Are Shareholders Getting a Fair Deal? PR Newswire
Oct-11-18 05:48PM  [$$] Gurnet Point to Take Corium Private The Wall Street Journal
04:03PM  Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares GlobeNewswire
Sep-24-18 07:30AM  Corium to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-06-18 04:22PM  Edited Transcript of CORI earnings conference call or presentation 9-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
Aug-29-18 07:30AM  Corium to Present at the H. C. Wainwright 20th Annual Global Investment Conference GlobeNewswire
Aug-09-18 06:00PM  Corium International (CORI) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:59PM  Corium: Fiscal 3Q Earnings Snapshot Associated Press
04:01PM  Corium Reports Third Quarter Fiscal 2018 Financial Results and Corporate Highlights GlobeNewswire
03:00PM  Corium International, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 07:30AM  Corium to Report Third Quarter Fiscal 2018 Financial Results on Thursday, August 9, 2018 GlobeNewswire
Jul-25-18 10:30AM  Corium Presents Additional Positive Clinical Results at Alzheimer's Association International Conference® 2018 GlobeNewswire
Jul-11-18 07:30AM  Corium Announces Issuance of Additional U.S. Patent Covering Corplex Donepezil Transdermal System for Alzheimers Disease GlobeNewswire
Jun-13-18 07:30AM  Corium Announces Issuance of Key U.S. Patent Covering Corplex Donepezil Transdermal System for Alzheimers Disease GlobeNewswire
Jun-11-18 08:15AM  New Research Coverage Highlights Monolithic Power, Ulta Beauty, Twenty-First Century Fox, Corium International, Independence Realty Trust, and Babcock & Wilcox Enterprises Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
May-24-18 08:00AM  Corium to Present at the Jefferies 2018 Global Healthcare Conference GlobeNewswire
May-21-18 07:00AM  Moving Average Crossover Alert: Corium International, Inc. (CORI) Zacks
May-16-18 01:42AM  Edited Transcript of CORI earnings conference call or presentation 14-May-18 9:00pm GMT Thomson Reuters StreetEvents
May-15-18 01:51PM  Corium International (CORI) Q2 2018 Earnings Conference Call Transcript Motley Fool +7.62%
May-14-18 04:50PM  Corium: Fiscal 2Q Earnings Snapshot Associated Press
04:01PM  Corium Reports Second Quarter Fiscal 2018 Financial Results and Corporate Highlights GlobeNewswire
12:45PM  Corium International, Inc. to Host Earnings Call ACCESSWIRE
May-08-18 08:00AM  Corium to Report Second Quarter Fiscal 2018 Financial Results on Monday, May 14, 2018 GlobeNewswire
Apr-13-18 09:38AM  Why the Earnings Streak Will Continue for Corium International (CORI) Zacks
Apr-12-18 09:37AM  CymaBay Therapeutics (CBAY) in Focus: Stock Moves 11.4% Higher Zacks
Mar-19-18 08:00AM  Corium to Present at the 17th Annual Needham Healthcare Conference GlobeNewswire
Mar-01-18 12:30PM  Here's Why Corium International Sank Today Motley Fool -6.92%
08:35AM  Corium Prices Offering of $100 Million of 5% Convertible Senior Notes GlobeNewswire
Feb-28-18 04:15PM  Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes; Receives FDA Feedback on Pilot Bioequivalence Study GlobeNewswire
Feb-09-18 07:56PM  Edited Transcript of CORI earnings conference call or presentation 8-Feb-18 10:00pm GMT Thomson Reuters StreetEvents
Feb-08-18 05:49PM  Corium reports 1Q loss Associated Press
04:03PM  Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights GlobeNewswire
01:50PM  Corium International, Inc. to Host Earnings Call ACCESSWIRE
Feb-06-18 08:00AM  Corium to Present at Upcoming Healthcare Investor Conferences GlobeNewswire
Feb-02-18 07:30AM  New Research: Key Drivers of Growth for Dova Pharmaceuticals, Park Electrochemical, Corium International, Sirius XM, Home Depot, and Walgreens Boots Alliance Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-01-18 04:05PM  Corium to Report First Quarter Fiscal 2018 Financial Results on Thursday, February 8, 2018 GlobeNewswire
Jan-19-18 04:00PM  Largest Insider Trades of the Week GuruFocus.com
Jan-01-18 09:08AM  Corium International, Inc. :CORI-US: Earnings Analysis: Q4, 2017 By the Numbers : January 1, 2018 Capital Cube
Dec-29-17 07:40AM  Free Research Report as Corium's Revenue Grew 19.2% ACCESSWIRE
06:48AM  Corium International Inc (CORI) Files 10-K for the Fiscal Year Ended on September 30, 2017 GuruFocus.com
Dec-27-17 11:19AM  Analyst Remains Confident In Corium Despite Partner's Bad FDA News Benzinga
Dec-26-17 10:55AM  What Should We Expect From Corium International Incs (NASDAQ:CORI) Earnings In Next 12 Months? Simply Wall St.
Dec-25-17 07:42AM  Corium International, Inc. breached its 50 day moving average in a Bearish Manner : CORI-US : December 25, 2017 Capital Cube
Dec-12-17 07:30AM  Corium to Join NASDAQ Biotechnology Index GlobeNewswire
Nov-24-17 10:53PM  Edited Transcript of CORI earnings conference call or presentation 16-Nov-17 10:00pm GMT Thomson Reuters StreetEvents +6.29%
Nov-17-17 09:13AM  Corium Q4 Sales Top Expectations Ahead Of Slew Of Near-Term Catalysts Benzinga +6.92%
Nov-16-17 04:19PM  Corium reports 4Q loss Associated Press +5.84%
04:02PM  Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights GlobeNewswire
12:10PM  Corium International, Inc. to Host Earnings Call ACCESSWIRE
Nov-14-17 03:20PM  Corium International, Inc. Value Analysis (NASDAQ:CORI) : November 14, 2017 Capital Cube
Nov-13-17 07:22AM  Corium International, Inc. breached its 50 day moving average in a Bullish Manner : CORI-US : November 13, 2017 Capital Cube
Nov-09-17 08:00AM  Corium to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, November 16, 2017 GlobeNewswire
Oct-30-17 11:36AM  ETFs with exposure to Corium International, Inc. : October 30, 2017 Capital Cube
Oct-26-17 08:04AM  Corium International, Inc. breached its 50 day moving average in a Bullish Manner : CORI-US : October 26, 2017 Capital Cube -5.10%
Oct-16-17 09:50AM  ETFs with exposure to Corium International, Inc. : October 16, 2017 Capital Cube
Sep-29-17 09:02AM  Corium International, Inc. :CORI-US: Earnings Analysis: Q3, 2017 By the Numbers : September 29, 2017 Capital Cube
Sep-05-17 08:00AM  Corium to Present at Upcoming Healthcare Conferences GlobeNewswire
Aug-24-17 09:00AM  Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole Marketwired +7.72%
Aug-12-17 08:01AM  Edited Transcript of CORI earnings conference call or presentation 3-Aug-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-04-17 02:36AM  Corium reports 3Q loss Associated Press
Aug-03-17 04:02PM  Corium Reports Recent Corporate Highlights and Financial Results for Third Quarter Fiscal 2017 GlobeNewswire
01:40PM  Investor Network: Corium International, Inc. to Host Earnings Call ACCESSWIRE
Jul-27-17 04:05PM  Corium to Report Third Quarter Fiscal 2017 Financial Results on Thursday, August 3, 2017 GlobeNewswire
Jul-18-17 07:30AM  Corium Presents Clinical Results from Pilot Bioequivalence Study of Corplex Donepezil Transdermal System at Alzheimer's Association International Conference® 2017 GlobeNewswire
Jul-07-17 08:15AM  Corium International (CORI) Catches Eye: Stock Jumps 11.9% Zacks
Jul-06-17 08:30AM  Corium to Present Clinical Results from Pilot Bioequivalence Study of Once-weekly Corplex Donepezil Transdermal System at Alzheimer's Association International Conference® 2017 GlobeNewswire +11.95%
Jun-26-17 08:30AM  Corium Joins Russell 3000® Index GlobeNewswire
Jun-01-17 08:30AM  Corium to Present at the Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-31-17 04:02PM  Corium Announces Closing of Follow-On Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
May-25-17 12:37PM  ETFs with exposure to Corium International, Inc. : May 25, 2017 Capital Cube
08:30AM  Corium Prices Follow-On Offering of Common Stock GlobeNewswire
May-24-17 04:03PM  Corium Announces Proposed Public Offering of Common Stock GlobeNewswire +7.51%
09:34AM  Corium International, Inc. :CORI-US: Earnings Analysis: Q2, 2017 By the Numbers : May 24, 2017 Capital Cube
May-22-17 08:20AM  AxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session Zacks
May-18-17 01:16PM  Edited Transcript of CORI earnings conference call or presentation 11-May-17 12:30pm GMT Thomson Reuters StreetEvents +9.00%
05:23AM  Can The Uptrend Continue for Corium International (CORI)? Zacks
May-12-17 11:44AM  Edited Transcript of CORI earnings conference call or presentation 11-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-11-17 09:16AM  Corium reports 2Q loss Associated Press +16.07%
07:02AM  Corium Reports Positive Preliminary Results in Alzheimers Clinical Study GlobeNewswire
07:00AM  Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights GlobeNewswire
May-09-17 08:30AM  Corium to Report Preliminary Results from Corplex Donepezil Pilot Study and Second Quarter Fiscal 2017 Financial Results Before Market Open on Thursday, May 11, 2017 GlobeNewswire +5.69%
May-03-17 11:17AM  Shire (SHPG) Beats on Q1 Earnings & Sales, Reiterates View Zacks
Apr-24-17 10:28AM  Anthem (ANTM) to Report Q1 Earnings: A Beat in the Cards? Zacks
Apr-07-17 04:13PM  ETFs with exposure to Corium International, Inc. : April 7, 2017 Capital Cube
Corium International, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of specialty pharmaceutical products in transdermal and transmucosal delivery systems. It offers Clonidine Transdermal Delivery System (TDS), a treatment for hypertension; Fentanyl TDS, a treatment for the management of chronic pain, including cancer-related pain; and Crest Whitestrips for teeth whitening. The company's products under pipeline comprise Twirla, a combination hormonal contraceptive patch, which has completed Phase III clinical trials to deliver ethinyl estradiol and levonorgestrel hormones; MicroCor hPTH(1-34), a transdermal system that has completed Phase 1 and Phase II a clinical trials for the treatment of severe osteoporosis; and Donepezil and Memantine transdermal systems, which completed Phase I clinical trials for the treatment of Alzheimer's disease. In addition, it develops Aripiprazole TDS for the treatment for psychiatric disorders; Corplex Ropinirole, a transdermal patch for the treatment of Parkinson's disease; and Motion Sickness Patch, a generic transdermal product for the prevention of nausea and vomiting associated with motion sickness. Corium International, Inc. has collaboration agreements with The Procter & Gamble Company; Teva Pharmaceuticals USA, Inc.; Agile Therapeutics, Inc.; and Aequus Pharmaceuticals, Inc. The company was incorporated in 1995 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PERCEPTIVE ADVISORS LLC10% OwnerOct 12Sale12.522,850,00035,677,0002,724,686Oct 15 04:56 PM
PERCEPTIVE ADVISORS LLC10% OwnerOct 11Sale12.50782,4479,783,4125,574,686Oct 15 04:56 PM
Sarret Joseph J.Chief Business OfficerAug 17Option Exercise0.0010,313019,775Aug 17 08:16 PM
STAPLE PETER DPresident & CEOAug 17Option Exercise0.007,8130284,890Aug 17 08:13 PM
Sweemer Timothy DChief Accounting OfficerAug 17Option Exercise0.001,250035,147Aug 17 08:19 PM
Singh ParminderCTO & Vice President, R&DAug 17Option Exercise0.009,063019,003Aug 17 08:17 PM
BREUIL ROBERT SChief Financial OfficerAug 17Option Exercise0.002,813015,413Aug 17 08:14 PM
STAPLE PETER DPresident & CEOAug 17Sale8.9737,021331,918247,869Aug 17 08:13 PM
BREUIL ROBERT SChief Financial OfficerAug 17Sale9.019728,75614,441Aug 17 08:14 PM
Sweemer Timothy DChief Accounting OfficerAug 17Sale9.013463,11734,801Aug 17 08:19 PM
Sarret Joseph J.Chief Business OfficerAug 17Sale9.013,56532,11616,210Aug 17 08:16 PM
Singh ParminderCTO & Vice President, R&DAug 17Sale9.013,13328,22415,870Aug 17 08:17 PM
STAPLE PETER DPresident & CEOAug 16Sale8.6639,320340,606277,077Aug 17 08:13 PM
STAPLE PETER DPresident & CEOAug 15Option Exercise2.12190,730404,538362,316Aug 17 08:13 PM
Thomas RobertDirectorAug 15Option Exercise2.1235,60875,52535,608Aug 17 07:50 PM
Thomas RobertDirectorAug 15Sale8.8635,608315,4760Aug 17 07:50 PM
STAPLE PETER DPresident & CEOMay 18Option Exercise2.1223,58650,026171,586May 22 03:01 PM
PERCEPTIVE ADVISORS LLC10% OwnerJan 18Buy12.80310,0003,968,0006,357,133Jan 18 05:21 PM
PERCEPTIVE ADVISORS LLC10% OwnerJan 17Buy12.24149,6501,831,7166,047,133Jan 18 05:21 PM
PERCEPTIVE ADVISORS LLC10% OwnerJan 16Buy11.8350,350595,6415,897,483Jan 18 05:21 PM
Broadfin Healthcare Master Fun10% OwnerNov 17Sale10.97199,6002,189,6333,568,626Nov 17 04:24 PM
Broadfin Healthcare Master Fun10% OwnerNov 16Sale10.95300,4003,290,1383,768,226Nov 17 04:24 PM
Broadfin Healthcare Master Fun10% OwnerNov 02Sale11.05150,0001,657,5004,068,626Nov 03 04:06 PM